Search results
Insider Sell: Amicus Therapeutics Inc President & CEO Bradley Campbell Sells 11,700 Shares
GuruFocus.com via Yahoo Finance· 8 months agoOn October 2, 2023, Bradley Campbell, President & CEO of Amicus Therapeutics Inc (NASDAQ:FOLD), sold...
Opinion/Letters: Permanent LNG facility is wrong for Aquidneck Island
The Newport Daily News via Yahoo News· 7 months agoWind farms are not the solution The article by Bradley Campbell in The Providence Journal supporting...
Conservation activists say wind farms are not killing whales off East Coast | Opinion
The Providence Journal via Yahoo News· 8 months agoBradley Campbell is president of the Conservation Law Foundation. As an organization that has spent...
Q4 2023 Amicus Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 months agoParticipants Andrew Faughnan Bradley Campbell; President, CEO; Amicus Therapeutics, Inc. Sébastien Martel; Chief Business Officer; Amicus Therapeutics, Inc. Jeff Castelli; Chief Development ...
Wind turbines are an inferior way to generate electricity. Here's why. | Opinion
The Providence Journal via Yahoo News· 7 months agoMiles Bidwell, Ph.D. has worked in the electricity industry for more than 40 years. He was one of...
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 months agoAmicus Therapeutics, Inc. (NASDAQ:FOLD) Q3 2023 Earnings Call Transcript November 8, 2023 Amicus...
Jim Florio was New Jersey's conservation trailblazer. We salute his work | Opinion
The Bergen Record via Yahoo News· 2 years agoThe pristine wilderness of the New Jersey Pine Barrens may seem worlds apart from the state’s...
Amicus Therapeutics Inc (FOLD) Reports 21% Revenue Growth in 2023, Eyes Non-GAAP Profitability ...
GuruFocus.com via Yahoo Finance· 3 months agoTotal Revenue: $399.4 million in 2023, marking a 21% increase year-over-year. Galafold Revenue: Grew by 18% to $387.8 million, with projections of 11-16% growth in 2024. Net Loss: Reduced to ...
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More:...
Benzinga via Yahoo Finance· 2 years agoEditor's note: This story has been corrected to reflect that the FDA deferred action on Amicus...
Meadowlark Media Launches ‘Sports Explains the World’ Series
Sportico via Yahoo Sports· 2 years agoMeadowlark Media, the content studio founded by former ESPN president John Skipper and ESPN radio...